Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-2.54M
↑ 98% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
$-150.54M
Historical baseline
PeriodValueYoY Change
2025$-2.54M+78.0%
2024$-11.53M+89.6%
2023$-110.61M+36.7%
2022$-174.66M+19.8%
2021$-217.83M+4.5%
2020$-228.16M-8.3%
2019$-210.69M-14.5%
2018$-183.94M+5.5%
2017$-194.56M-13.8%
2016$-170.91M-